PMID- 33846471 OWN - NLM STAT- MEDLINE DCOM- 20211102 LR - 20211102 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 11 IP - 1 DP - 2021 Apr 12 TI - Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis. PG - 7984 LID - 10.1038/s41598-021-87095-0 [doi] LID - 7984 AB - This study aimed to investigate the influence of TPMT*3C, ITPA, NUDT15, and 6-thioguanine nucleotides (6-TGN) on azathioprine (AZA)-induced myelosuppression in Southwest China patients with autoimmune hepatitis (AIH). A total of 113 Chinese patients with AIH receiving AZA maintenance treatment were evaluated. The relevant clinical data of the patients were collected from the hospital information system. Genotyping of TPMT*3C(rs1142345), ITPA (rs1127354) and NUDT15(rs116855232) was conducted using a TaqMan double fluorescent probe. The concentration of 6-TGN was determined using UPLC-MS/MS. Among AIH patients treated with AZA, 40 (35.4%) exhibited different degrees of myelosuppression. The NUDT15 variant was associated with leukopenia (P = 8.26 x 10(-7); OR = 7.5; 95% CI 3.08-18.3) and neutropenia (P = 3.54 x 10(-6); OR = 8.05; 95% CI 2.96-21.9); however, no significant association with myelosuppression was observed for TPMT*3C and ITPA variants (P > 0.05). There was no significant difference in 6-TGN concentration between AIH patients with or without myelosuppression (P = 0.556), nor was there a significant difference between patients with variant alleles of TPMT*3C, ITPA, or NUDT15 and wild-type patients (P > 0.05). Interestingly, it was found that patients with a lower BMI had higher adjusted 6-TGN levels and a higher incidence of myelosuppression (P = 0.026 and 0.003). This study confirmed that NUDT15 variants are a potential independent risk predictor for AZA-induced leukopenia and neutropenia. BMI may be a crucial non-genetic factor that affects the concentration of AZA metabolites and myelosuppression. In addition, the 6-TGN concentration in red blood cells does not reflect the toxicity of AZA treatment, and new biomarkers for AZA therapeutic drug monitoring need further research. FAU - Miao, Qiang AU - Miao Q AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. FAU - Yan, Lin AU - Yan L AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. FAU - Zhou, Yanhong AU - Zhou Y AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. FAU - Li, Yi AU - Li Y AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. FAU - Zou, Yuangao AU - Zou Y AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. FAU - Wang, Lanlan AU - Wang L AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. FAU - Bai, Yangjuan AU - Bai Y AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. whitewcums@126.com. FAU - Zhang, Junlong AU - Zhang J AD - Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, No.37, Guoxue Xiang, Wuhou District, Chengdu, 610041, China. immune_hx@126.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210412 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Guanine Nucleotides) RN - 0 (Thionucleotides) RN - 15867-02-4 (6-thioguanylic acid) RN - EC 2.1.1.- (Methyltransferases) RN - EC 2.1.1.67 (TPMT protein, human) RN - EC 2.6.1.- (NUDT15 protein, human) RN - EC 3.6.1.- (Pyrophosphatases) RN - EC 3.6.1.9 (ITPA protein, human) RN - MRK240IY2L (Azathioprine) SB - IM MH - Adult MH - Aged MH - Alleles MH - Azathioprine/*adverse effects MH - China MH - Female MH - *Genetic Association Studies MH - Guanine Nucleotides MH - Hepatitis, Autoimmune/drug therapy/*genetics MH - Humans MH - Leukopenia/*chemically induced/genetics MH - Male MH - Methyltransferases/*genetics MH - Middle Aged MH - Mutation/*genetics MH - Phenotype MH - Pyrophosphatases/*genetics MH - Thionucleotides PMC - PMC8042108 COIS- The authors declare no competing interests. EDAT- 2021/04/14 06:00 MHDA- 2021/11/03 06:00 PMCR- 2021/04/12 CRDT- 2021/04/13 06:14 PHST- 2020/12/07 00:00 [received] PHST- 2021/03/23 00:00 [accepted] PHST- 2021/04/13 06:14 [entrez] PHST- 2021/04/14 06:00 [pubmed] PHST- 2021/11/03 06:00 [medline] PHST- 2021/04/12 00:00 [pmc-release] AID - 10.1038/s41598-021-87095-0 [pii] AID - 87095 [pii] AID - 10.1038/s41598-021-87095-0 [doi] PST - epublish SO - Sci Rep. 2021 Apr 12;11(1):7984. doi: 10.1038/s41598-021-87095-0.